The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Dose analysis of ASSURE (E2805): Adjuvant sorafenib or sunitinib for unfavorable renal carcinoma, an ECOG-ACRIN-led, NCTN phase 3 trial.
 
Naomi B. Haas
Stock and Other Ownership Interests - TetraLogic Pharmaceuticals (I)
Consulting or Advisory Role - Bristol-Myers Squibb; GlaxoSmithKline; Merck
Expert Testimony - Lilly (I)
 
Judith Manola
No Relationships to Disclose
 
Keith Flaherty
Stock and Other Ownership Interests - Clovis Oncology; Loxo
Consulting or Advisory Role - Amgen; Genentech; GlaxoSmithKline; Lilly; Merck; Momenta Pharmaceuticals; Novartis; Oncoceutics; Sanofi; Viralytics; ZIOPHARM Oncology
Research Funding - Novartis; Sanofi
Travel, Accommodations, Expenses - GlaxoSmithKline; Sanofi
 
Robert G. Uzzo
Honoraria - GlaxoSmithKline; Johnson & Johnson
Consulting or Advisory Role - Myriad Genetics
Speakers' Bureau - Janssen Oncology
 
Michael B. Atkins
Honoraria - Bristol-Myers Squibb
Consulting or Advisory Role - Amgen; C-Cam; Genentech; GlaxoSmithKline; Lilly; Merck; Neostem; Novartis; Novartis; Pfizer; X4 Pharma
 
Janice P. Dutcher
No Relationships to Disclose
 
Christopher G. Wood
Consulting or Advisory Role - Ono Pharmaceutical
Research Funding - Argos Therapeutics; Boehringer Ingelheim; GlaxoSmithKline; Ono Pharmaceutical; Pfizer
Travel, Accommodations, Expenses - Argos Therapeutics
 
Christopher J. Kane
No Relationships to Disclose
 
Michael A. S. Jewett
Employment - Impact Genetics (I)
Leadership - Impact Genetics (I)
Stock and Other Ownership Interests - Impact Genetics (I)
Honoraria - Janssen Oncology; Myriad Genetics; Novartis; Pfizer
Consulting or Advisory Role - Theralase
Research Funding - Olympus Medical Systems (Inst)
Patents, Royalties, Other Intellectual Property - Patent application filed for a new RFA device
 
Bob Coomes
No Relationships to Disclose
 
Surena F. Matin
No Relationships to Disclose
 
Timothy Kuzel
Honoraria - Amgen; Argos Therapeutics; Astellas Pharma; Bayer/Onyx; Bionomics; Celgene; Eisai; Genentech/Roche; Janssen
Speakers' Bureau - Astellas Pharma; Bayer; Celgene; Genentech/Roche; Janssen Oncology
Research Funding - Bayer/Onyx (Inst); Bristol-Myers Squibb (Inst); CureTech (Inst); Eisai (Inst); Genentech/Roche (Inst); MedImmune (Inst); Merck/Schering Plough (Inst); Millennium (Inst)
Travel, Accommodations, Expenses - Argos Therapeutics; Astellas Pharma; Bayer/Onyx; Celgene; elorac; Genentech; Janssen Oncology
 
Wade Jeffers Sexton
No Relationships to Disclose
 
Yu-Ning Wong
Research Funding - Bayer (Inst); Janssen (Inst); Medivation (Inst); Millennium (Inst); Pfizer (Inst)
Travel, Accommodations, Expenses - eviti
 
Toni K. Choueiri
Honoraria - NCCN; UpToDate
Consulting or Advisory Role - AVEO; Bayer; GlaxoSmithKline; Novartis; Pfizer
Research Funding - Bristol-Myers Squibb (Inst); Exelixis (Inst); GlaxoSmithKline (Inst); Merck (Inst); Novartis (Inst); Pfizer (Inst); TRACON Pharma (Inst)
Travel, Accommodations, Expenses - Bayer; Bristol-Myers Squibb; GlaxoSmithKline; Novartis; Pfizer
 
Roberto Pili
Research Funding - Pfizer
 
Igor Puzanov
No Relationships to Disclose
 
Manish Kohli
No Relationships to Disclose
 
Walter Michael Stadler
Honoraria - Bayer; CVS Caremark; Dendreon; Johnson & Johnson; medpacto; Merck; Millennium; Novartis; Roche/Genentech; Veridex
Consulting or Advisory Role - Bayer; CVS Caremark; Dendreon; Genentech/Roche; Medivation; medpacto; Millennium; Novartis; Sotio; Veridex
Research Funding - Active Biotech (Inst); Bayer (Inst); Boehringer Ingelheim (Inst); Bristol-Myers Squibb (Inst); Dendreon (Inst); Exelixis (Inst); Genentech/Roche (Inst); GlaxoSmithKline (Inst); Lilly/ImClone (Inst); Medivation (Inst); Novartis (Inst); Pfizer (Inst); Takeda (Inst)
Other Relationship - UpToDate
 
Robert S. DiPaola
No Relationships to Disclose